|
|
Environ Health Perspect. 1997 September; 105(9): 972–978. | PMCID: PMC1470354 |
Research Article Residential exposure to plasticizers and its possible role in the pathogenesis of asthma. L Oie, L G Hersoug, and J O Madsen National Institute of Public Health, Department of Population Health Sciences, Oslo, Norway. Abstract The plasticizer di(2-ethylhexyl) phthalate (DEHP) is widely used in building materials. DEHP is identified as the major plasticizer exposure in dwellings. We provide evidence that inhalation exposure to DEHP as aerosols adsorbed to particulate matter is as important, or more important, than vapor phase exposure. The particulate inhalation exposure to DEHP is considered to be significant due to its low clearance and extensive penetration into the pulmonary region. DEHP is capable of creating high local concentrations in the airways at the deposition site with subsequent local effects. The proposed mechanism of effect states that mono(2-ethylhexyl) phthalate (MEHP), the primary hydrolysis product of DEHP, mimics the inducing prostaglandins (PG) PGD(2), 9alpha,11betaPGF2, and PGF2alpha, and thromboxanes in the lungs, thereby increasing the risk of inducing inflammation in the airways, which is a characteristic of asthma. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Images in this article Click on the image to see a larger version. These references are in PubMed. This may not be the complete list of references from this article. - Burr ML. Is asthma increasing? J Epidemiol Community Health. 1987 Sep;41(3):185–189. [PubMed]
- Magnus P, Kongerud J, Bakke JV. Har vi en astmaepidemi? Tidsskr Nor Laegeforen. 1991 Mar 20;111(8):972–975. [PubMed]
- Burney PG, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ. 1990 May 19;300(6735):1306–1310. [PubMed]
- Anderson HR, Butland BK, Strachan DP. Trends in prevalence and severity of childhood asthma. BMJ. 1994 Jun 18;308(6944):1600–1604. [PubMed]
- Peat JK, van den Berg RH, Green WF, Mellis CM, Leeder SR, Woolcock AJ. Changing prevalence of asthma in Australian children. BMJ. 1994 Jun 18;308(6944):1591–1596. [PubMed]
- Rimpelä AH, Savonius B, Rimpelä MK, Haahtela T. Asthma and allergic rhinitis among Finnish adolescents in 1977-1991. Scand J Soc Med. 1995 Mar;23(1):60–65. [PubMed]
- Richards W. Hospitalization of children with status asthmaticus: a review. Pediatrics. 1989 Jul;84(1):111–118. [PubMed]
- Sivertsen B, Clench-Aas J. Exposure to environmental chemicals relevant for respiratory hypersensitivity: European aspects. Toxicol Lett. 1996 Aug;86(2-3):143–153. [PubMed]
- Martinez FD, Cline M, Burrows B. Increased incidence of asthma in children of smoking mothers. Pediatrics. 1992 Jan;89(1):21–26. [PubMed]
- Stoddard JJ, Miller T. Impact of parental smoking on the prevalence of wheezing respiratory illness in children. Am J Epidemiol. 1995 Jan 15;141(2):96–102. [PubMed]
- Cunningham J, O'Connor GT, Dockery DW, Speizer FE. Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med. 1996 Jan;153(1):218–224. [PubMed]
- Pershagen G, Rylander E, Norberg S, Eriksson M, Nordvall SL. Air pollution involving nitrogen dioxide exposure and wheezing bronchitis in children. Int J Epidemiol. 1995 Dec;24(6):1147–1153. [PubMed]
- Korsgaard J. Mite asthma and residency. A case-control study on the impact of exposure to house-dust mites in dwellings. Am Rev Respir Dis. 1983 Aug;128(2):231–235. [PubMed]
- Dust mite allergens and asthma--a worldwide problem. J Allergy Clin Immunol. 1989 Feb;83(2 Pt 1):416–427. [PubMed]
- Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, Woolcock AJ. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med. 1996 Jan;153(1):141–146. [PubMed]
- Strachan DP, Sanders CH. Damp housing and childhood asthma; respiratory effects of indoor air temperature and relative humidity. J Epidemiol Community Health. 1989 Mar;43(1):7–14. [PubMed]
- Brunekreef B, Dockery DW, Speizer FE, Ware JH, Spengler JD, Ferris BG. Home dampness and respiratory morbidity in children. Am Rev Respir Dis. 1989 Nov;140(5):1363–1367. [PubMed]
- Jaakkola JJ, Jaakkola N, Ruotsalainen R. Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Expo Anal Environ Epidemiol. 1993;3(Suppl 1):129–142. [PubMed]
- Andrae S, Axelson O, Björkstén B, Fredriksson M, Kjellman NI. Symptoms of bronchial hyperreactivity and asthma in relation to environmental factors. Arch Dis Child. 1988 May;63(5):473–478. [PubMed]
- Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. [PubMed]
- Frew AJ. The immunology of respiratory allergies. Toxicol Lett. 1996 Aug;86(2-3):65–72. [PubMed]
- Nordman H, Keskinen H, Tuppurainen M. Formaldehyde asthma--rare or overlooked? J Allergy Clin Immunol. 1985 Jan;75(1 Pt 1):91–99. [PubMed]
- Burge PS, Harries MG, Lam WK, O'Brien IM, Patchett PA. Occupational asthma due to formaldehyde. Thorax. 1985 Apr;40(4):255–260. [PubMed]
- Doelman CJ, Borm PJ, Bast A. Plasticisers and bronchial hyperreactivity. Lancet. 1990 Mar 24;335(8691):725. [PubMed]
- Nafstad P, Jaakkola JJ, Hagen JA, Botten G, Kongerud J. Breastfeeding, maternal smoking and lower respiratory tract infections. Eur Respir J. 1996 Dec;9(12):2623–2629. [PubMed]
- Nikkari T, Schreibman PH, Ahrens EH., Jr In vivo studies of sterol and squalene secretion by human skin. J Lipid Res. 1974 Nov;15(6):563–573. [PubMed]
- Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev. 1988 Mar;40(1):49–84. [PubMed]
- Chung KF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax. 1986 Sep;41(9):657–662. [PubMed]
- Fuller RW, Dixon CM, Dollery CT, Barnes PJ. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis. 1986 Feb;133(2):252–254. [PubMed]
- Jongejan RC, de Jongste JC, Raatgeep RC, Stijnen T, Bonta IL, Kerrebijn KF. Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine. Am Rev Respir Dis. 1990 Nov;142(5):1129–1132. [PubMed]
- Murray JJ, Tonnel AB, Brash AR, Roberts LJ, 2nd, Gosset P, Workman R, Capron A, Oates JA. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med. 1986 Sep 25;315(13):800–804. [PubMed]
- Kurosawa M, Yodonawa S, Tsukagoshi H. Inhibition of 9 alpha,11 beta-prostaglandin F2-induced bronchial hyperresponsiveness by thromboxane A2 receptor antagonists in guinea pigs. Eur J Pharmacol. 1993 Jul 20;238(2-3):335–341. [PubMed]
- Gardiner PJ. Eicosanoids and airway smooth muscle. Pharmacol Ther. 1989;44(1):1–62. [PubMed]
- Norel X, Labat C, Gardiner PJ, Brink C. Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations. Br J Pharmacol. 1991 Nov;104(3):591–595. [PubMed]
- Doelman CJ, Borm PJ, Bast A. Plasticisers, another burden for asthmatics? Agents Actions Suppl. 1990;31:81–84. [PubMed]
- Schulz CO, Rubin RJ, Hutchins GM. Acute lung toxicity and sudden death in rats following the intravenous administration of the plasticizer, di(2-ethylhexyl)phthalate, solubilized with Tween surfactants. Toxicol Appl Pharmacol. 1975 Sep;33(3):514–525. [PubMed]
- Roth B, Herkenrath P, Lehmann HJ, Ohles HD, Hömig HJ, Benz-Bohm G, Kreuder J, Younossi-Hartenstein A. Di-(2-ethylhexyl)-phthalate as plasticizer in PVC respiratory tubing systems: indications of hazardous effects on pulmonary function in mechanically ventilated, preterm infants. Eur J Pediatr. 1988 Jan;147(1):41–46. [PubMed]
- Shukla RR, Albro PW, Corbett JT, Schroeder JL. In vitro studies of the inhibition of protein kinase C from rat brain by di-(2-ethylhexyl)phthalate. Chem Biol Interact. 1989;69(1):73–85. [PubMed]
- Johnston SL, Bardin PG, Harrison J, Ritter W, Joubert JR, Holgate ST. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. Br J Clin Pharmacol. 1992 Nov;34(5):402–408. [PubMed]
- Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Gennaro V, Higgins MW, Sorlie PD, Ko WJ, Szklo M. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1994 Jul 28;331(4):228–233. [PubMed]
- Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991 Sep;54(3):438–463. [PubMed]
- Schmidt EB, Dyerberg J. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs. 1994 Mar;47(3):405–424. [PubMed]
|
This article has been 
